SCHEMBL4599325

SCHEMBL4599325

C=CC(=O)NC(CC)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
POLB P06746 1/20 0.39
ALDH1A1 P00352 4/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TGFBR1 P36897 1/20 0.37
ZDHHC20 Q5W0Z9 1/20 0.37
ZDHHC2 Q9UIJ5 1/20 0.37
TGM2 P21980 3/20 0.37
MME P08473 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
NFKB1 P19838 1/20 0.36
PTGS2 P35354 1/20 0.36
THPO P40225 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28421 0.84 TSHR (0.47) TSHRTDP1ZDHHC20ZDHHC2TGM2
SCHEMBL8185037 0.84 TSHR (0.47) TSHRTDP1ZDHHC20ZDHHC2TGM2
SCHEMBL23870419 0.82 PSMB5 (0.43) TSHRPOLBALDH1A1MAPK1TDP1
SCHEMBL28459310 0.82 POLB (0.38) POLBALDH1A1MMEKDM4EMAPT
SCHEMBL8186011 0.81 TGM2 (0.50) TSHRMAPK1ZDHHC20ZDHHC2TGM2
SCHEMBL1562504 0.81 TGM2 (0.50) TSHRMAPK1ZDHHC20ZDHHC2TGM2
SCHEMBL6513640 0.81 TGFBR1 (0.52) TSHRALDH1A1MAPK1TDP1TGFBR1
SCHEMBL6513633 0.81 TGFBR1 (0.52) TSHRALDH1A1MAPK1TDP1TGFBR1
SCHEMBL8188102 0.80 ALDH1A1 (0.60) TSHRALDH1A1MAPTFOLH1NAALAD2
SCHEMBL27828839 0.80 ALDH1A1 (0.60) TSHRALDH1A1MAPTFOLH1NAALAD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12638614-B2 Method for making silicone hydrogel contact lenses ALCON INC. (CH) 2026-05-26 US claimed
EP-4514596-B1 METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES ALCON INC (CH) 2026-03-04 EP claimed
EP-4369081-B1 METHOD FOR PRODUCING AN OPHTHALMIC PRODUCT ALCON INC (CH) 2025-06-25 EP claimed
US-12247169-B2 Method for making photochromic contact lenses ALCON INC. (CH) 2025-03-11 US claimed
EP-4514597-A1 METHOD FOR MAKING UV AND HEVL-ABSORBING OPHTHALMIC LENSES Alcon Inc. (CH) 2025-03-05 EP claimed
EP-4514596-A1 METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2025-03-05 EP claimed
US-12116442-B2 Method for producing silicone hydrogel contact lenses ALCON INC. (CH) 2024-10-15 US claimed
US-20240287379-A1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES ALCON INC. (CH) 2024-08-29 US claimed
US-11999908-B2 Method for making photochromic contact lenses ALCON INC. (CH) 2024-06-04 US claimed
EP-4146461-B1 METHOD FOR PRODUCING SILICONE HYDROGEL CONTACT LENSES ALCON INC (CH) 2024-03-13 EP claimed
CN-114981072-A Wettable silicone hydrogel contact lenses 爱尔康公司 2022-08-30 CN claimed
CN-114502362-A Contact lenses with surfaces of varying softness 爱尔康公司 2022-05-13 CN claimed
CN-110831990-B Poly (meth) acrylamide-based copolymers with carboxyl-terminated side chains 爱尔康公司 2022-02-01 CN claimed
EP-1435380-B1 Polymer additive for ink-jet inks to improve durability HEWLETT PACKARD DEVELOPMENT CO (US) 2008-04-16 EP claimed
US-6858301-B2 Specific core-shell polymer additive for ink-jet inks to improve durability HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2005-02-22 US claimed
US-20040131855-A1 SPECIFIC CORE-SHELL POLYMER ADDITIVE FOR INK-JET INKS TO IMPROVE DURABILITY HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2004-07-08 US claimed
EP-1435380-A1 Polymer additive for ink-jet inks to improve durability Hewlett-Packard Development Company, L.P. (US) 2004-07-07 EP claimed
US-6716949-B2 PREPARED BY POLYMERIZING AT LEAST AN UNSATURATED HYDROPHOBIC MONOMER, AND AN UNSATURATED MONOMER CONTAINING A CONVERTIBLE MOIETY THAT IS HYDROPHOBIC IN AN ACIDIC ENVIRONMENT AND HYDROPHILIC IN A BASIC ENVIRONMENT. HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2004-04-06 US claimed
US-20030198648-A1 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA ACHILION PHARMACEUTICALS 2003-10-23 US claimed
WO-2003060098-A2 METHODS FOR IDENTIFYING COMPOUNDS WHICH INHIBIT BINDING OF NUCLEOCAPSID 7 PROTEIN TO HIV-1 RNA ACHILLION PHARMACEUTICALS, INC. (US) 2003-07-24 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12638614-B2 Method for making silicone hydrogel contact lenses SMCHD1, CRYAA, CRYZ TSHR 1465/4885POLB 2857/4885ALDH1A1 2364/4885
US-20030198648-A1 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA MRPS27, SNRPE, NSUN2 TSHR 4796/4885POLB 255/4885ALDH1A1 4104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.